Samrat Pharmachem

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue69.2157.8480.0462.0982.98
Expenses70.0057.0979.8161.9581.60
EBITDA-0.461.130.530.531.65
EBIT-0.620.970.370.371.50
Profit Before Tax-0.790.750.240.141.39
Net Profit-0.740.61-0.190.341.40
Financial Ratios
Operating Profit Margin-0.66%1.97%0.66%0.86%2.00%
Net Profit Margin-1.07%1.06%-0.24%0.55%1.69%
Earning Per Share (Diluted)-2.411.98-0.611.114.52
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ